Thirty Years of Evidence on the Efficacy of Drug Treatments for Chronic Heart Failure With Reduced Ejection Fraction: A Network Meta-Analysis

Burnett, Heather, Earley, Amy, Voors, Adriaan A., Senni, Michele, McMurray, John J.V., Deschaseaux, Celine, Cope, Shannon·2017·Circulation Heart Failure
DOI 10.1161/circheartfailure.116.003529

Cited by (238)

Items 101–200 of 238

  1. Preventing Cardiomyopathy in DMD
    John P. Bourke, Gillian C. Watson, Stefan Spinty, Andrew Bryant, Helen Roper, Thomas J. Chadwick, Ruth Wood, Elaine McColl, Kate Bushby, Francesco Muntoni A et al. · 2020 · Neurology Clinical Practice
  2. Variation in use and dosing escalation of renin angiotensin system, mineralocorticoid receptor antagonist, angiotensin receptor neprilysin inhibitor and beta-blocker therapies in heart failure and reduced ejection fraction: Association of comorbidities
    Nancy M. Albert, Rachel Tyson, C. Larry Hill, Adam D. DeVore, John A. Spertus, Carol I. Duffy, Javed Butler, James Herbert Patterson, Adrian F. Hernandez, Fredonia B. Williams et al. · 2021 · American Heart Journal
  3. Heart Failure Spending Function: An Investment Framework for Sequencing and Intensification of Guideline-Directed Medical Therapies
    Larry A. Allen, John R. Teerlink, Stephen S. Gottlieb, Tariq Ahmad, Carolyn S.P. Lam, Mitchell A. Psotka · 2022 · Circulation Heart Failure
  4. Focused Treatment of Heart Failure with Reduced Ejection Fraction Using Sacubitril/Valsartan
    Rex C. Liu · 2018 · American Journal of Cardiovascular Drugs
  5. Decentralization and Integration of Advanced Cardiac Care for the World’s Poorest Billion Through the PEN-Plus Strategy for Severe Chronic Non-Communicable Disease
    Sheila Liu Klassen, Emmy Okello, Jose Maria E. Ferrer, Faraz Alizadeh, Prebo Barango, Pilly Chillo, Yamikani F Chimalizeni, Wubaye Walelgne Dagnaw, Jean-Luc Eiselé, Lauren Anne Eberly et al. · 2024 · Global Heart
  6. Hydralazine–Isosorbide Dinitrate Use in Patients With End-Stage Kidney Disease on Dialysis
    Thomas A. Mavrakanas, Qandeel H. Soomro, David M. Charytan · 2022 · Kidney International Reports
  7. Guideline-directed medical therapy in heart failure patients with reduced ejection fraction in Oman: utilization, reasons behind non-prescribing, and dose optimization
    Safiya Al-Aghbari, Juhaina Salim Al-Maqbali, Abdullah Mohammed Al Alawi, Mohammed Al Za’abi, Ibrahim S Al-Zakwani · 2022 · Pharmacy Practice
  8. BRD4 Silencing Protects Angiotensin II-Induced Cardiac Hypertrophy by Inhibiting TLR4/NF-κB and Activating Nrf2-HO-1 Pathways
    Ming Fang, Jun Luo, Xi Zhu, Yingbiao Wu, Xinming Li · 2022 · Cardiology Research and Practice
  9. Prognostic Significance of Medical Therapy in Patients with Heart Failure with Reduced Ejection Fraction
    Umut Kocabaş, Işıl Ergin, Tarık Kıvrak, Gülsüm Meral Yılmaz Öztekin, Veysel Ozan Tanık, İbrahim Halil Özdemir, Fulya Avcı Demir, Mustafa Doğduş, Taner Şen, Meltem Altınsoy et al. · 2023 · ESC Heart Failure
  10. Iatrogenic Decompensated Heart Failure
    Patrick Tran, Prithwish Banerjee · 2020 · Current Heart Failure Reports
  11. ACE inhibitor and ARB therapy: Practical recommendations
    Hernan Rincon-Choles · 2019 · Cleveland Clinic Journal of Medicine
  12. Short-Term Effects of Sacubitril/Valsartan Therapy on Myocardial Oxygen Consumption and Energetic Efficiency of Cardiac Work in Heart Failure with Reduced Ejection Fraction: A Randomized Controlled Study
    Sergey V. Nesterov, Johanna Räty, Wail Nammas, Teemu Maaniitty, Xavier Galloo, Jan Stassen, Sanna Laurila, Tuija Vasankari, Jenni Huusko, Jeroen Joost Bax et al. · 2023 · European Journal of Heart Failure
  13. Network Meta-Analysis Comparing Angiotensin Receptor-Neprilysin Inhibitors, Angiotensin Receptor Blockers, and Angiotensin-Converting Enzyme Inhibitors in Heart Failure With Reduced Ejection Fraction
    Dae Yong Park, Seokyung An, Steve Attanasio, Neeraj Jolly, Saurabh Malhotra, Rami Doukky, Marc D. Samsky, Sounok Sen, Tariq Ahmad, Michael G. Nanna et al. · 2022 · The American Journal of Cardiology
  14. Economic Evaluations of Pharmacological Treatments in Heart Failure Patients: A Methodological Review with a Focus on Key Model Drivers
    Gian Luca Di Tanna, Shuxian Chen, Anna Bychenkova, Heidi S. Wirtz, Karen L. Burrows, Gary A. Globe · 2019 · PharmacoEconomics - Open
  15. Mildly Symptomatic Heart Failure with Reduced Ejection Fraction: Diagnostic and Therapeutic Considerations
    Alexandra Arvanitaki, Eleni Michou, Andreas P. Kalogeropoulos, Haralambos I. Karvounis, George A. Giannakoulas · 2020 · ESC Heart Failure
  16. AI-Enabled Assessment of Cardiac Systolic and Diastolic Function from Echocardiography
    Esther Puyol Anton, Bram Ruijsink, Baldeep Singh Sidhu, Justin Gould, Bradley Porter, Mark K. Elliott, V S Mehta, Haotian Gu, Christopher A. Rinaldi, Martín Cowie et al. · 2022 · Lecture notes in computer science
  17. A Modern History RAAS Inhibition and Beta Blockade for Heart Failure to Underscore the Non-equivalency of ACEIs and ARBs
    Daniel A. Hyman, Vince Siebert, Gilad D. Birnbaum, Mahboob Alam, Yochai Birnbaum · 2020 · Cardiovascular Drugs and Therapy
  18. Myocardial Cell Signaling During the Transition to Heart Failure
    Matthew R. Zeglinski, Adel Rezaei Moghadam, Sudharsana Rao Ande, Kimia Sheikholeslami, Pooneh Mokarram, Zahra Sepehri, Haleh Rokni, Nima Khadem Mohtaram, Mansour Poorebrahim, Anahita Masoom et al. · 2018 · Comprehensive physiology
  19. Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Withdrawal Is Associated with Higher Mortality in Hospitalized Patients with COVID-19
    Emilia Roy‐Vallejo, Aquilino Sánchez Purificación, José David Torres-Peña, Beatriz Sánchez Moreno, Francisco Arnalich, María José García Blanco, José López‐Miranda, Juan Luis Romero‐Cabrera, Carmen Rosario Herrero Gil, José Bascuñana et al. · 2021 · Journal of Clinical Medicine
  20. Biomarker-Guided vs Guideline-Directed Titration of Medical Therapy for Heart Failure
    Gregg C. Fonarow · 2017 · JAMA
  21. Additional mineralocorticoid receptor antagonists in heart failure underdosed with guideline-directed medication
    Takuro Abe, Shota Shirotani, Takuma Takada, Ayano Yoshida, Shun Hasegawa, Makoto Kishihara, Noritoshi Fukushima, Kozue Saito, Junichi Yamaguchi, Kentaro Jujo · 2024 · Journal of the Renin-Angiotensin-Aldosterone System
  22. Effects of cardiac medications on ventricular function in patients with Duchenne muscular dystrophy–related cardiomyopathy
    Alexander Peter Murphy, Anna Johnson, Volker W. Straub, Alison Heads‐Baister, Stephen W. Lord, John P. Bourke · 2021 · Muscle & Nerve
  23. Sudden death mechanisms in nonischemic cardiomyopathies: Insights gleaned from clinical implantable cardioverter-defibrillator trials
    Benjamin Adam Steinberg, Siva K. Mulpuru, James C. Fang, Bernard John Gersh · 2017 · Heart Rhythm
  24. Rationale for and Practical Use of Sacubitril/Valsartan in the Patient’s Journey with Heart Failure and Reduced Ejection Fraction
    Mauro Gori, James L. Januzzi, Emilia D’Elia, Ferdinando Luca Lorini, Michele Senni · 2021 · Cardiac failure review
  25. Palliative Care in Heart Failure: Challenging Prognostication
    Inês Egídio de Sousa, Ana Carolina Pedroso, Beatriz Chambino, Marta Roldão, Fausto Pinto, Renato Guerreiro, Inês Araújo, Celia Coelho Henriques, Cândida Fonseca · 2021 · Cureus
  26. Optimizing Therapies in Heart Failure: The Role of Potassium Binders
    Pietro Scicchitano, Massimo Iacoviello, Francesco Massari, Micaela De Palo, Pasquale Caldarola, Antonia Mannarini, Andrea Passantino, Marco Matteo Ciccone, Michele Magnesa · 2022 · Biomedicines
  27. The ability of modern therapy to improve the prognosis of patients with HF: role of angiotensin neprilysin inhibitors and sodium-glucose cotransporter inhibitors
    Yu. V. Mareev, Mareev VIu · 2021 · Kardiologiia
  28. Cost-Effectiveness Analysis of Sacubitril/Valsartan Compared to Enalapril for Heart Failure Patients in Indonesia
    Neily Zakiyah, R. Sinuraya, A. S. Kusuma, A. Suwantika, Keri Lestari · 2021 · ClinicoEconomics and Outcomes Research
  29. Drug therapy monitoring (TDM) of Digoxin: safety and efficacy review
    Rony Abdi Syahputra, Urip Harahap, Aminah Dalimunthe, Muhammad Pandapotan Nasution, Denny Satria · 2022 · Pharmacia
  30. Proteomic and metabolomic analyses of the human adult myocardium reveal ventricle-specific regulation in end-stage cardiomyopathies
    Benjamin Hunter, Mengbo Li, Benjamin L. Parker, Yen Chin Koay, Dylan Harney, Evangeline Pearson, Jacob Cao, Gavin T. Chen, Oneka Guneratne, Gordon K. Smyth et al. · 2024 · Communications Biology
  31. Pediatric heart failure: Current approach and treatment
    Benjamin A. Olsen, Shelley D. Miyamoto · 2025 · JHLT Open
  32. Red Blood Cell Distribution Width: A Risk Factor for Prognosis in Patients with Ischemic Cardiomyopathy after Percutaneous Coronary Intervention
    Biyang Zhang, Yinxiao Xu, Xin Huang, Tienan Sun, Meishi Ma, Zheng Chen, Yujie Zhou · 2023 · Journal of Clinical Medicine
  33. Effects of Sacubitril/Valsartan According to Background Beta-Blocker Therapy in Patients with Heart Failure and Reduced Ejection Fraction: Insights from PARADIGM-HF
    Sharmistha Datta Gupta, Jawad H. Butt, Eoghan G. M. McMurray, Atefeh Talebi, Shingo Matsumoto, Adel R. Rizkala, Alasdair David Henderson, Akshay Suvas Desai, Martin P. Lefkowitz, Milton Packer et al. · 2024 · European Journal of Heart Failure
  34. Pharmacotherapy treatment patterns at hospital discharge and clinical outcomes among patients with heart failure with reduced ejection fraction
    Yuttana Wongsalap, Duangkamon Poolpun, Konrapee Keawhai, Napusson Kitpluem, Parichat Pansiri, Siriluck Malaimat, Vichai Senthong, Kirati Kengkla · 2023 · Chronic Diseases and Translational Medicine
  35. Heart Failure Treatment and the Art of Medical Decision Making
    Finlay Aleck McAlister, Justin Adrian Ezekowitz, Paul W. Armstrong · 2019 · European Journal of Heart Failure
  36. Beneficial Effect of Left Ventricular Remodeling after Early Change of Sacubitril/Valsartan in Patients with Nonischemic Dilated Cardiomyopathy
    Hyue Mee Kim, Kyung‐Hee Kim, Jin-Sik Park, Byung‐Hee Oh · 2021 · Medicina
  37. Effect of angiotensin receptor-neprilysin inhibitor on atrial electrical instability in atrial fibrillation
    Tianyu Zhu, Wenchao Zhang, Yang Quan, Ning Wang, Yuwei Fu, Yan Li, Guanliang Cheng, Liang Wang, Xian Zhang, Hongying Yao et al. · 2022 · Frontiers in Cardiovascular Medicine
  38. Ion channel trafficking implications in heart failure
    Jean‐Baptiste Reisqs, Yongxia Sarah Qu, Mohamed Boutjdir · 2024 · Frontiers in Cardiovascular Medicine
  39. Impact of hyperkalaemia on renin–angiotensin–aldosterone (RAAS) inhibitor reduction or withdrawal following hospitalisation
    Hugh Logan Ellis, Mohammad Al-Agil, Philip A. Kelly, James Teo, Claire C. Sharpe, Martin Whyte · 2024 · Clinical and Experimental Medicine
  40. Comparative cardiovascular outcomes of novel drugs as an addition to conventional triple therapy for heart failure with reduced ejection fraction (HFrEF): a network meta-analysis of randomised controlled trials
    Thanakit Suebsaicharoen, Puri Chunekamrai, Teerapat Yingchoncharoen, Amarit Tansawet, Thanaphruet Issarawattana, Pawin Numthavaj, Ammarin Thakkinstian · 2023 · Open Heart
  41. Comparative effectiveness of Omicron XBB 1.5-adapted COVID-19 vaccines: a systematic literature review and network meta-analysis
    Kyle R. Fahrbach, Allie B. Cichewicz, Haitao Chu, Manuela Di Fusco, Heather F Burnett, Hannah R. Volkman, Morodoluwa Akin‐Fajiye, Carlos Fernando Mendoza, Joseph C. Cappelleri · 2025 · Expert Review of Vaccines
  42. Use of sodium zirconium cyclosilicate for up-titration of renin–angiotensin–aldosterone system inhibitor therapy in patients with heart failure: a case series
    Rhys Williams, Alex James, Moira Ashton, Sian Vaughan, Aaron Wong · 2021 · European Heart Journal - Case Reports
  43. Prescription drug coverage in high cardiovascular risk patients as an important part of the national goals achievement
    A. E. Soloveva, А. Н. Яковлев, Aleksey N. Yakovlev, Виллевальде Светлана Вадимовна, Н. Э. Звартау, Шляхто Евгений Владимирович, Evgeniy Shlyahto · 2019 · Вестник Росздравнадзора
  44. Real‐World Associations Between Renin‐Angiotensin‐Aldosterone System Inhibition Therapy, Hyperkalemia, and Outcomes: A Clinical and Scientific Call to Action
    Arlene B. Chapman, Samantha Gunning · 2019 · Journal of the American Heart Association
  45. Physicians’ adherence to the guidelines on the chronic heart failure diagnosis and treatment
    Н. Б. Перепеч, А. В. Трегубов, I. E. Mikhailova · 2022 · Kardiologiia
  46. The effects of triblock copolymer nano-vesicles loaded with propolis on heart failure model of rats
    Lin Bai, Bolin Jiang, Ke Xiao, Hui He, Lei Huang · 2023 · Arabian Journal of Chemistry
  47. Objectively measured medication adherence using assays for carvedilol and enalaprilat in patients with heart failure in Mozambique and Nigeria
    Julius Chacha Mwita, Andrè Joubert, Hadiza Saidu, Mahmoud Umar Sani, Albertino Antonio Moura Damasceno, Ana Olga Mocumbi, Phumla Sinxadi, Charle Andre Viljoen, Julian Hoevelmann, Manna Semere Gebreyesus et al. · 2023 · International Journal of Cardiology Cardiovascular Risk and Prevention
  48. Clinical mesenchymal stem cell therapy in ischemic cardiomyopathy
    Amine Mazine, Dinela Rushani, Terrence M. Yau · 2021 · JTCVS Open
  49. Is Heart Failure Etiology Destiny?
    James E. Udelson · 2019 · JACC Heart Failure
  50. The Relation Between Red Blood Cell Distribution Width and Coronary Atherosclerotic Plaque Vulnerability Detected by Intracoronary Optical Coherence Tomography
    Peng Jin, Sijing Wu, Qian Ma, Wei Liu, Yingxin Zhao, Hongya Han, Fangjie Hou, Ya Li, Yujie Zhou · 2022 · Current Vascular Pharmacology
  51. Polypharmacology in Clinical Applications: Cardiovascular Polypharmacology
    Zhiguo Wang, Baofeng Yang · 2022 · Springer eBooks
  52. Guía mexicana de práctica clínica para el diagnóstico y el tratamiento de la insuficiencia cardiaca
    Abel Alberto Pavía López, Antonio Magaña-Serrano, José A. Cigarroa-López, Adolfo Chávez‐Mendoza, José Luis Mayorga-Butrón, Diego Araiza Garaygordobil, Juan Betuel Ivey-Miranda, Gustavo F. Méndez-Machado, Héctor González-Godínez, Luisa Fernanda Aguilera Mora et al. · 2024 · Archivos de cardiología de México
  53. Lung cancer risk and the inhibitors of angiotensinconverting enzyme: A mini-review of recent evidence
    Masoumeh Asgharpour, Mohammad Ebrahimi Kalan, Seyed Hadi Mirhashemi, Amirhesam Alirezaei · 2019 · Immunopathologia Persa
  54. HIPERTENSÃO ARTERIAL E INSUFICIÊNCIA CARDÍACA: ANÁLISE CRÍTICA DOS NOVOS FÁRMACOS
    Centro de Tratamento do Diabético, Hipertenso e Portador de Insuficiência Cardíaca (CADHI) de Cabo Frio, RJ, Brasil., Anderson Wilnes Wilnes Simas Pereira, Beatriz Castello Branco Miranda, Bruno Wilnes Simas Pereira, Raphael Eltink Trad Coutinho · 2021 · Revista Brasileira de Hipertensão
  55. The Association between Marital Status and Outcomes of Patients Hospitalized with Heart Failure
    Leonid Maizels, Wesam Mulla, Avishay Grupper, Arsalan Abu‐Much, Sharon Shalom Natanzon, Eias Massalha, Israel Mazin, Anan Younis · 2022 · International Journal of Behavioral Medicine
  56. Neue medikamentöse Therapieansätze bei chronischer Herzinsuffizienz
    Tibor Kempf, Udo Bavendiek, Johann K Bauersachs · 2017 · Der Internist
  57. Optimizing Medical Therapy in Chronic Worsening HFrEF
    Adam Phillip Bress, Jordan B. King · 2019 · Journal of the American College of Cardiology
  58. A review on recent insights on cardiovascular diseases drug design using natural products and in silico studies
    S. N. Ugariogu, N. Al-Tannak, S. Alenezi · 2025 · Maǧallaẗ Al-Kuwayt li-l-ʿulūm
  59. Heart Failure
    Margaret Bowers, Tonya Carter · 2023 · Nursing Clinics of North America
  60. A Focus on Heart Failure Management through Diet and Nutrition: A Comprehensive Review
    Lee Patricia Liao, Anushriya Pant, Simone L. Marschner, Peter L Talbot, Sarah J. Zaman · 2024 · Hearts
  61. Aggressive beta-blocker titration in stabilized acute heart failure patients with low left ventricular ejection fraction
    Yoga Waranugraha, Mohammad Saifur Rohman, Dion Setiawan, Indra Jabbar Aziz · 2021 · Journal of Taibah University Medical Sciences
  62. Towards an artificial intelligence-augmented, ECG-enabled physical exam
    Christine P. Shen, Evan D. Muse · 2022 · The Lancet Digital Health
  63. Antagonistic Atrial Natriuretic Peptide with the Renin-Angiotensin-Aldosterone System and Effects on Systemic Blood Pressure Regulation
    Fellipe Genasculi Araujo, Rogério Rodrigo Ramos · 2022 · Journal of Modern Medicinal Chemistry
  64. Efficacy and safety of Zhenyuan capsule in the treatment of chronic heart failure: A meta-analysis and trial sequential analysis
    Zengyu Zhang, Jianhe Liu · 2023 · Medicine
  65. Shift of Conventional Paradigm of Heart Failure Treatment: From Angiotensin Receptor Neprilysin Inhibitor to sodium–glucose co-transporter 2 inhibitors?
    Alexander Е. Berezin, Alexander A. Berezin · 2021 · Future Cardiology
  66. Combination Drug Therapy in Heart Failure: Greater Than the Sum of its Parts
    Andrew P. Ambrosy, Ovidiu Chioncel · 2018 · European Journal of Heart Failure
  67. New horizons in cardiogeriatrics: geriatricians and heart failure care—the custard in the tart, not the icing on the cake
    Shuli Levy, Graham Cole, Punam Pabari, Melanie Dani, Carys Barton, Jamil Mayet, Theresa A. McDonagh, John K. Baxter, Carla M. Plymen · 2021 · Age and Ageing
  68. Incidence and Predictors of Progression in Asymptomatic Patients With Stable Heart Failure
    Alexander Marschall, Hugo del Castillo Carnevali, Concepción Fernández Pascual, Ana Lorente Rubio, María José Morales Gallardo, Carmen Dejuán Bitriá, Freddy Andrés Delgado Calva, Juan Duarte Torres, Belén Biscotti Rodíl, Diego José Rodríguez Torres et al. · 2021 · The American Journal of Cardiology
  69. Therapeutic Feasibility of the Natural Products in the Heart Complaints: An Overview
    Priscila de Souza, Luísa Nathália Bolda Mariano, Rita de Cássia M.V.A.F. da Silva, Francielli Gasparotto, Emerson Luiz Botelho Lourenço, Guilherme Donadel, Thaise Boeing, Arquimedes Gasparotto · 2021 · Journal of Medicinal Food
  70. A retrospective cohort review of prescribing in hospitalised patients with heart failure using Beers criteria and STOPP recommendations
    Janine Beezer, Lisa Roe, Andy Husband · 2022 · Journal of Pharmacy Practice and Research
  71. Is Any Patient with Chronic Heart Failure Receiving the Right Dose of the Right Beta-Blocker in Primary Care?
    Milton Packer · 2019 · The American Journal of Medicine
  72. Myocardial Cell Signaling During the Transition to Heart Failure
    Matthew R. Zeglinski, Adel Rezaei Moghadam, Sudharsana Rao Ande, Kimia Sheikholeslami, Pooneh Mokarram, Zahra Sepehri, Haleh Rokni, Nima Khadem Mohtaram, Mansour Poorebrahim, Anahita Masoom et al. · 2019 · Comprehensive physiology
  73. Effect of ketone supplementation, a low-carbohydrate diet and a ketogenic diet on heart failure measures and outcomes: a systematic review and meta-analysis
    Lee Patricia Liao, Lauren Adriel Church, Hannah Melville, Thilini N. Jayasinghe, Carina Choy, Aileen Zeng, Nikki Barrett, Simone L. Marschner, Gaofeng Gan, Liza Thomas et al. · 2025 · Heart
  74. Recent advances in implantable hydrogels for treating heart failure
    Huining Wan, Chenwei Sun, Jieyu Zhang, Xuefeng Hu, Yunbing Wang · 2022 · Journal of Applied Polymer Science
  75. Guideline-directed medical therapy in heart failure patients with reduced ejection fraction in Palestine: Retrospective clinical audit study
    Ammar Abdulrahman Jairoun, Sabaa Saleh Al‐Hemyari, Moyad Jamal Shahwan, Sa’ed H. Zyoud, Maimona Jairoun · 2024 · Saudi Pharmaceutical Journal
  76. Association of Angiotensin Receptor-Neprilysin Inhibitors Use and Better Cardiorenal Outcomes in Patients With Heart Failure and Acute Kidney Disease
    Jui‐Yi Chen, Heng‐Chih Pan, Vin‐Cent Wu · 2025 · Cardiovascular Drugs and Therapy
  77. What's New in Heart Failure? May 2025
    Mert Tokcan, Julian Hoevelmann, Philipp Markwirth, Bernhard Haring · 2025 · European Journal of Heart Failure
  78. Alternative payment models and innovation: a case study of US health system adoption of a sacubitril/valsartan to treat acute decompensated heart failure
    Jason T. Shafrin, Elmar R. Aliyev, Michelle Brauer, Siyeon Park, Xian Shen · 2020 · Journal of Medical Economics
  79. Cost-Effectiveness of Treating Patients with Chronic Kidney Disease and Prior Hyperkalemia with Renin–Angiotensin–Aldosterone System Inhibitor and Patiromer: A Swiss Public Healthcare Perspective
    Barbara Fischer, Andreas L. Serra, Harry Telser · 2022 · Advances in Therapy
  80. The evolving face of heart failure management
    M. Kalsi, Nalin H. Dayawansa, Josh Winderlich, G. Vaddadi · 2022 · Australian Journal of General Practice
  81. ‘A Missed Therapeutic Opportunity? SGLT-2 Inhibitor Use in General Medicine Patients With Heart Failure: A Retrospective Audit of Admissions to a Tertiary Health Service’
    Padeepa Perera, Ronan O’Donnabhain, Timothy Nicholas Fazio, Douglas Forsyth Johnson, Peter Lange · 2022 · Clinical Medicine Insights Cardiology
  82. Heart failure and inhibition of renin-angiotensin-aldosteron system
    Jiří Vítovec, Jindřich Špinar, Lenka Špinarová · 2018 · Cor et Vasa
  83. Beta-blocker therapy in pediatric heart failure
    Reiner Buchhorn · 2021 · Annals of Pediatric Cardiology
  84. Tratamiento actual de la falla cardiaca con fracción de expulsión reducida
    Jairo Alfonso Gándara-Ricardo, Edison Muñoz-Ortiz, Oswaldo E. Aguilar-Molina, Karen Andrea García-Rueda, Santiago Giraldo-Ramírez, Jhon F Salamanca, Juan Manuel Sénior · 2021 · Acta Médica Colombiana
  85. The Changing Face of Heart Failure
    James E. Udelson · 2017 · JACC. Cardiovascular imaging
  86. Guideline-Directed Medical Management of Heart Failure with Reduced Ejection Fraction: Improved Outcomes With Quadruple Therapy
    Kristin M. Stawiarski, Harish Ramakrishna · 2022 · Journal of Cardiothoracic and Vascular Anesthesia
  87. Assessment of left ventricular function with gated myocardial perfusion SPECT and gated myocardial FDG PET in patients with left ventricular mechanical dyssynchrony
    Frank Philipp Graner, Maximilian Fischer, Harun Ilhan, Peter Bartenstein, Andrei S. Todica, Sebastian LEHNER · 2021 · The Quarterly Journal of Nuclear Medicine and Molecular Imaging
  88. Nebivolol for the Treatment of Arrhythmias: a Narrative Review
    Lucian Mureşan, Radu Roşu, Gabriel Laurentiu Cismaru, Gabriel Guşetu, Crina Muresan, Raphaël Pedro Martins, Stefan‐Lucian Popa, Jacques Lévy, Sebastian Trancă · 2022 · Current Treatment Options in Cardiovascular Medicine
  89. Medical Costs and Economic Impact of Hyperkalemia in a Cohort of Heart Failure Patients with Reduced Ejection Fraction
    Andrea López‐López, Margarita Regueiro‐Abel, Emilio Paredes-Galán, Charigan Abou Johk-Casas, Jose María Viéitez-Flórez, Juliana Elices‐Teja, Jorge Armesto Rivas, Raúl Franco‐Gutiérrez, Ramón Ríos-Vázquez, Carlos González‐Juanatey · 2024 · Journal of Clinical Medicine
  90. Impact of polypharmacy phenogroups on different heart failure phenotypes in patients with chronic heart failure: a retrospective examination of real-world cohort
    A. Sukik, A. Aboughalia, Abdul Haseeb Said Wali, A. al-Radaideh, O. M. Elsayed, M. Amer, J. Abuodeh, Oyelola A Adegboye, Abdelnaser Elzouki, M. Danjuma · 2025 · Frontiers in Pharmacology
  91. Midodrine in the management of heart failure with reduced ejection fraction: a systematic review
    N. Pavic, Shane Zhang, E. Zhou, A. Maloof, Stephen Bacchi, Joshua Kovoor, Dennis Lau, A. Zaka, Joanne Eng-Frost, P. Kovoor · 2025 · Internal medicine journal (Print)
  92. Antihypertensive therapy to prevent cardiac death: A study of combined ACE inhibitors and β-blockers—a retrospective cohort study in Tsunan Town, Japan
    Shinichiro Ishikawa, Yusaku Hayashi, Toshiyuki Abe, Susumu Tanaka · 2025 · PLoS ONE
  93. Echocardiographic Insights into the Hemodynamics of Systolic Heart Failure: Can This Guide Titration of Medical Therapy?
    Richard Kar-Hang Cheng, Wayne C. Levy · 2018 · Journal of the American Society of Echocardiography
  94. 高齢者心不全におけるフレイルの影響
    玄彦 大中, 重和 藤岡 · 2021 · Journal of allied health sciences
  95. Current approaches to preventing heart failure readmissions and decompensated disease
    Matthew MACE, Niklas Lidströmer · 2023 · Minerva Cardiology and Angiology
  96. Sex differences in clinical characteristics, management, and outcomes in patients admitted for ventricular tachycardia: 2016–2018
    Narut Prasitlumkum, Ronpichai Chokesuwattanaskul, Wisit Kaewput, Charat Thongprayoon, Wisit Cheungpasitporn, Krit Jongnarangsin, Koonlawee Nademanee · 2023 · Journal of Cardiovascular Electrophysiology
  97. Impact of Sex and Gender Differences on Heart Failure, Especially in Elderly Patients
    Giuseppe Cocco, Hans Peter Hofmann, Stefano Pandolfi · 2024 · OBM Geriatrics
  98. Progress in drug treatment of older patients with chronic heart failure
    Siting Zhang, Feng Liu · 2020 · Aging Pathobiology and Therapeutics
  99. The Impact of Mineralocorticoid Receptor Antagonist Use on All-cause Mortality in Acute Heart Failure Patients
    Ibrahim S Al-Zakwani, Mohammed Al‐Jarallah, Rajesh Rajan, Kadhim Sulaiman, Raja Dashti, Bassam Bulbanat, AlawiA Alsheikh-Ali, Prashanth Panduranga, Khalid F. AlHabib, Jassim M. S. Al Suwaidi et al. · 2021 · Annals of Clinical Cardiology
  100. Chronic heart failure: a review of pharmacotherapy management
    Letícia de Oliveira Pinto, Carlos Eduardo Braga Filho, Matheus Ritto, Flávia de Sousa Gehrke, Juliane Vismari de Oliveira, Marcelo Pires-Oliveira, Rafael Guzella de Carvalho, Fernando Sabia Tallo, Murched Omar Taha, Francisco Sandro Menezes Rodrigues · 2022 · Research Society and Development